Key facts
- It has raised $3.5M; the latest was Seed Round ($3.5M) in Jan 2025.
- Notable investors include Microsoft for Startups, AWS Startups, Imperial Enterprise Lab.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Lymbic AI
- ·The full record, as it builds
Funding rounds
No funding rounds for Lymbic AI are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Lymbic AI
Developer of an AI-based biometric platform designed to securely interpret brainwaves captured by emerging neural devices to use in real-time. The company's platform offers few wearable devices that ensures privacy by using advanced encryption keeping raw brain data local and secure, ensures long-term accuracy and durability, making it tied to the user over time, activates continuous authentication, in which a user's identity can be verified in real time as they interact with a system, enabling users to get wearable neural devices to decode captured brain signals in real time.
- Sector
- Information Technology
- HQ
- London, United Kingdom
- Founded
- 2021
- Employees
- 4
- Website
- lymbic.ai/
- Ownership
- Privately Held (backing)
Lymbic AI doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Lymbic AI shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Lymbic AI in its N-PORT filings yet. We sweep new filings monthly.